Topical Colchicine Gel versus Diclofenac Sodium Gel for the Treatment of Actinic Keratoses: A Randomized, Double-Blind Study.
Introduction. Actinic keratoses (AKs), a premalignant skin lesion, are a common lesion in fair skin. Although destructive treatment remains the gold standard for AKs, medical therapies may be preferable due to the comfort and reliability .This study aims to compare the effects of topical 1% colchicine gel and 3% diclofenac sodium gel in AKs. Materials and Methods. In this randomized double-blind study, 70 lesions were selected. Patients were randomized before receiving either 1% colchicine gel or 3% diclofenac sodium cream twice a day for 6 weeks. Patients were evaluated in terms of their lesion size, treatment complications, and recurrence at 7, 30, 60, and 120 days after treatment. Results. The mean of changes in the size was significant in both groups both before and after treatment (<0.001). The mean lesion size before treatment and at 30, 60, and 120 days was not different between the two groups (p > 0.05). No case of erythema was seen in the colchicine group, while erythema was seen in 22.9% (eight cases) of patients in the diclofenac sodium group (p = 0.005). Conclusions. 1% colchicine gel was a safe and effective medication with fewer side effects and lack of recurrence of the lesion.
Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Gita
G
Faghihi
Department of Dermatology, Qom University of Medical Sciences, Qom, Iran.
Azam
0000-0003-3864-0022
A
Elahipoor
Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Fariba
F
Iraji
Department of Dermatology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Shadi
S
Behfar
Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Bahareh
B
Abtahi-Naeini
Indian J Dermatol Venereol Leprol. 2010 Mar-Apr;76(2):201-5
20228563
J Dermatolog Treat. 2001 Dec;12(4):199-203
12241628
Int J Dermatol. 2001 Nov;40(11):709-13
11737438
Cutis. 2003 May;71(5):373-9
12769404
Semin Cutan Med Surg. 2003 Sep;22(3):162-70
14649583
Br J Clin Pharmacol. 1980 Sep;10(3):297-300
7437248
Am Fam Physician. 2003 Nov 15;68(10):1955-60
14655804
Indian J Dermatol Venereol Leprol. 2006 Sep-Oct;72(5):346-9
17050927
Br J Dermatol. 2016 Feb;174(2):260-1
26871916
Pharmacotherapy. 1991;11(3):196-211
1862011
Arch Dermatol Res. 2005 Nov;297(5):185-9
16235081
Dermatology. 2000;200(4):346-8
10894974
N Engl J Med. 2012 Mar 15;366(11):1010-9
22417254
Am J Otolaryngol. 2009 Mar-Apr;30(2):121-33
19239954
J Am Acad Dermatol. 2014 Jun;70(6):979.e1-12; quiz 9912
24831325
Int Rev Cytol. 1973;34:333-61
4267164
N Engl J Med. 2004 Apr 8;350(15):1526-34
15071127
J Pharmacol Exp Ther. 1982 Oct;223(1):197-202
7120118
Am Fam Physician. 2003 Nov 15;68(10):1963-8
14655805
Am Fam Physician. 2007 Sep 1;76(5):667-71
17894135